PATENT CLAIM ANALYSIS

Application Number: 15994999
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "093200"]

Abstract:
Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.

Claim (Index 88):
The method of  claim 87 , wherein the targeting protein binds to collagen, laminin, fibronectin, elastin, glycosaminoglycans, proteoglycans or RGD.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.275
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14214448', '14214522', '15892295', '10457604', '12319640']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7317863293548268
- 35 USC 102 Novelty (BERT): 0.6288452310469359
- Combined Prediction Score: 0.7214922195240377
- Mean Citation Score: 416.24180000000007
- Max Citation Score: 628.63104
- Similarity Product: 503.577413964386

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test